Thanks, but no thanks

| | Comments (0)

Abilify© may be the first mood-enhancing drug whose commercials spend more time on the disclaimer listing the sundry - and extraordinarily worrisome - potential side effects than on actually trying to sell you the product. (I've seen the commercial a lot on news channels lately, which should tell you something.) The commercial goes something like this:

"Depressed? Take Abilify©.

2644325544_5c84bf2797.jpg

"Abilify© could increase risk of suicide in children, adolescents, and young adults with Major Depressive Disorder. It can also cause neuroleptic malignant syndrome, Tardive Dyskinesia, hyperglycemia and Diabetes Mellitus, Orthostatic Hypotension, esophageal dysmotility, seizures and/or convulsions, the potential for Cognitive and Motor Impairment, and suicide. It can also cause akathisia, extrapyramidal disorder, dizziness somnolence and tremor, fatigue, nausea, blurred vision, salivary hypersecretion and complete organ failure, sometimes but not always resulting in death.

landscape-tuscan.jpg

"Consult your doctor if symptoms persist. Do not take Abilify© if you want to live past age 35 or have ever had the sniffles or a bruise or a skin abrasion.

"Abilify©. Because it's slightly better than being depressed."

cropped_smiling_couple.jpg

Leave a comment

About this blog

david-kronke.jpgDavid Kronke was appointed Mayor of Television after a bloodless coup in 2000. Since then, he has improved infrastructure, championed greater educational opportunities and fought for reforms that have utterly erased corruption and incompetence from the television industry. Since Mr. Kronke has ascended to power, Television is a far better place.

About this Entry

This page contains a single entry by David Kronke published on February 4, 2009 7:46 PM.

Reality TV's effects on one's self worth can be devastating was the previous entry in this blog.

Next: on "Lost" is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Recent Comments

Powered by Movable Type 4.21-en